Cyclopharm (ASX:CYC) announces the first signed U.S. contract for Technegas with Duke University Hospital following approval of by the USFDA on 29 September 2023 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20231205/pdf/05y66m6jl37slv.pdf #CYC #USA #Technegas #shorts
JAV
0.003
50%
ERA
0.001
-50%
SNX
0.029
45%
FBR
0.005
-28.6%
AAU
0.004
33.3%
BTN
0.105
-25%
BNL
0.008
33.3%
CMG
0.1
-23.1%
GGE
0.004
33.3%
CCM
0.036
-20%
SRK
0.045
32.4%
SHP
0.004
-20%
TASDA
0.023
27.8%
AAJ
0.009
-18.2%
CTT
0.58
27.5%
ADN
0.014
-17.6%
PHO
0.083
25.8%
LKY
0.034
-17.1%
CHM
0.005
25%
ATH
0.01
-16.7%
HCT
0.07
25%
ROG
0.005
-16.7%
ICG
0.005
25%
SKK
0.005
-16.7%
RMI
0.005
25%
DTR
0.027
-15.6%
APX
1.147
21.4%
NWM
0.011
-15.4%
BKT
0.029
20.8%
AJL
0.006
-14.3%
IFG
0.006
20%
ARV
0.006
-14.3%
PV1
0.012
20%
KPO
0.006
-14.3%
AUA
0.031
19.2%
LMG
0.012
-14.3%
AHK
0.25
19%
PCL
0.012
-14.3%
IAM
0.025
19%
PGY
0.006
-14.3%
